ALG6-CDG (CDG-Ic)
Other Names: CDG 1C; CDG1C; Carbohydrate-deficient glycoprotein syndrome type 1C; Carbohydrate-deficient glycoprotein syndrome, type 1 with deficient glycosylation of dolichol-linked oligosaccharide (formerly); Carbohydrate-deficient glycoprotein syndrome, type V (formerly); CDGS5 (formerly); ALG6-CDG (CDG-Ic); CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; ALG6-CDG; Carbohydrate deficient glycoprotein syndrome type Ic; CDG syndrome type Ic; CDG-Ic; Congenital disorder of glycosylation type 1c; Congenital disorder of glycosylation type Ic; Glucosyltransferase 1 deficiency
A form of congenital disorders of N-linked glycosylation characterized by feeding problems, mild-to-moderate neurologic involvement with hypotonia, poor head control, developmental delay, ataxia, strabismus, and seizures, ranging from febrile convulsions to epilepsy. Retinal degeneration has also been reported. A minority of patients show other manifestations, particularly intestinal (such as protein-losing enteropathy) and liver involvement. The disease is caused by loss of function mutations of the gene ALG6 (1p31.3).
NIH genetic and rare disease info[edit source]
ALG6-CDG (CDG-Ic) is a rare disease.
ALG6-CDG (CDG-Ic) Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Deepika vegiraju